110 related articles for article (PubMed ID: 34580038)
1. Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survival.
Pelizzaro F; Peserico G; D'Elia M; Cazzagon N; Russo FP; Vitale A; Giannini EG; Piccinnu M; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Sacco R; Cabibbo G; Marra F; Mega A; Morisco F; Gasbarrini A; Svegliati-Baroni G; Foschi FG; Olivani A; Masotto A; Nardone G; Raimondo G; Azzaroli F; Vidili G; Oliveri F; Trevisani F; Farinati F;
Dig Liver Dis; 2022 Jul; 54(7):927-936. PubMed ID: 34580038
[TBL] [Abstract][Full Text] [Related]
2. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
3. Improved Survival of Hepatocellular Carcinoma Patients Diagnosed with a Dedicated Screening Programme-a Propensity Score Adjusted Analysis.
Chinnaratha MA; Campbell K; Mathias R; McCormick RJ; Woodman RJ; Wigg AJ
J Gastrointest Cancer; 2019 Dec; 50(4):888-893. PubMed ID: 30345486
[TBL] [Abstract][Full Text] [Related]
4. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
Schauer C; Mules T; Rijnsoever MV; Gane E
N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
[TBL] [Abstract][Full Text] [Related]
5. Improved survival with radiotherapy in hepatocellular carcinoma with major vascular invasion: A propensity-matched analysis of Surveillance, Epidemiology, and End Results database.
Lin Q; Huang X; Zhong C; Luo T; Zeng X; Chen S
Cancer Med; 2019 Feb; 8(2):515-526. PubMed ID: 30656831
[TBL] [Abstract][Full Text] [Related]
6. Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients.
Cabibbo G; Celsa C; Calvaruso V; Petta S; Cacciola I; Cannavò MR; Madonia S; Rossi M; Magro B; Rini F; Distefano M; Larocca L; Prestileo T; Malizia G; Bertino G; Benanti F; Licata A; Scalisi I; Mazzola G; Di Rosolini MA; Alaimo G; Averna A; Cartabellotta F; Alessi N; Guastella S; Russello M; Scifo G; Squadrito G; Raimondo G; Trevisani F; Craxì A; Di Marco V; Cammà C;
J Hepatol; 2019 Aug; 71(2):265-273. PubMed ID: 30959157
[TBL] [Abstract][Full Text] [Related]
7. Patients with non-viral liver disease have a greater tumor burden and less curative treatment options when diagnosed with hepatocellular carcinoma.
Mohsen W; Rodov M; Prakoso E; Charlton B; Bowen DG; Koorey DJ; Shackel NA; McCaughan GW; Strasser SI
World J Gastroenterol; 2017 Apr; 23(15):2763-2770. PubMed ID: 28487614
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification.
Lee M; Chang Y; Oh S; Cho YY; Jung DE; Kim HH; Nam JY; Cho H; Cho EJ; Lee JH; Yu SJ; Yi NJ; Lee KW; Lee DH; Lee JM; Yoon JH; Suh KS; Kim YJ
Gut Liver; 2018 Sep; 12(5):571-582. PubMed ID: 29730905
[TBL] [Abstract][Full Text] [Related]
9. Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation.
Chen PH; Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Huo TI; Huang YH; Wu WC; Chao Y; Lin HC; Wu JC
Ann Hepatol; 2013; 12(2):263-73. PubMed ID: 23396738
[TBL] [Abstract][Full Text] [Related]
10. Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.
Pecorelli A; Lenzi B; Gramenzi A; Garuti F; Farinati F; Giannini EG; Ciccarese F; Piscaglia F; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Sacco R; Cabibbo G; Felder M; Morisco F; Gasbarrini A; Baroni GS; Foschi FG; Biasini E; Masotto A; Virdone R; Bernardi M; Trevisani F;
Liver Int; 2017 Mar; 37(3):423-433. PubMed ID: 27566596
[TBL] [Abstract][Full Text] [Related]
11. The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
Shen J; Liu J; Li C; Wen T; Yan L; Yang J
Dig Dis Sci; 2018 Jul; 63(7):1962-1969. PubMed ID: 29736828
[TBL] [Abstract][Full Text] [Related]
12. Natural History of Untreated Hepatocellular Carcinoma in a US Cohort and the Role of Cancer Surveillance.
Khalaf N; Ying J; Mittal S; Temple S; Kanwal F; Davila J; El-Serag HB
Clin Gastroenterol Hepatol; 2017 Feb; 15(2):273-281.e1. PubMed ID: 27521507
[TBL] [Abstract][Full Text] [Related]
13. Early stage hepatocellular carcinoma in the elderly: A SEER database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
J Geriatr Oncol; 2017 Jul; 8(4):277-283. PubMed ID: 28389117
[TBL] [Abstract][Full Text] [Related]
14. Sorafenib use in hepatitis B virus- or hepatitis C virus-related hepatocellular carcinoma: A propensity score matching study.
Lee YC; Wang JH; Chen CH; Hung CH; Lo KC; Yen YH; Kee KM; Hu TH; Lu SN; Kuo YH
Kaohsiung J Med Sci; 2021 Oct; 37(10):894-902. PubMed ID: 34166565
[TBL] [Abstract][Full Text] [Related]
15. The Optimal Management for Sub-Centimeter Hepatocellular Carcinoma: Curative Treatments or Follow-Up?
Sun X; Zhang Y; Lyu N; Li X; Chen M; Zhao M
Med Sci Monit; 2019 Jul; 25():4941-4951. PubMed ID: 31270311
[TBL] [Abstract][Full Text] [Related]
16. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
[TBL] [Abstract][Full Text] [Related]
17. Clinical Patterns and Outcome of Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
Ahn SY; Kim SB; Song IH
Can J Gastroenterol Hepatol; 2020; 2020():4873875. PubMed ID: 32566546
[TBL] [Abstract][Full Text] [Related]
18. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
[TBL] [Abstract][Full Text] [Related]
19. Survival of hepatocellular carcinoma patients may be improved in surveillance interval not more than 6 months compared with more than 6 months: a 15-year prospective study.
Han KH; Kim DY; Park JY; Ahn SH; Kim J; Kim SU; Kim JK; Lee KS; Chon CY
J Clin Gastroenterol; 2013 Jul; 47(6):538-44. PubMed ID: 23340065
[TBL] [Abstract][Full Text] [Related]
20. Surveillance for hepatocellular carcinoma in elderly Italian patients with cirrhosis: effects on cancer staging and patient survival.
Trevisani F; Cantarini MC; Labate AM; De Notariis S; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
Am J Gastroenterol; 2004 Aug; 99(8):1470-6. PubMed ID: 15307862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]